OcuTerra Therapeutics
Jeffery S. Heier, MD, is the Co-President and Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston. He is on the Executive Board of the Retina Society and the Executive Committee of the American Society of Retina Specialists. He is also the President of the New England Ophthalmological Society, and a member of the Macula Society. In addition to having authored or co-authored numerous works in peer-reviewed journals, Jeffery has served as a reviewer for the New England Journal of Medicine, Lancet, Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, Retina, and numerous other journals. Jeffery was also an investigator in the OTT166 Phase 1/Phase 2 clinical studies.
This person is not in the org chart
This person is not in any offices
OcuTerra Therapeutics
OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity